Tanvir Md Amit Hasan, Khaleque Md Abdul, Lee Junhee, Park Jong-Beom, Kim Ga-Hyun, Lee Hwan-Hee, Kim Young-Yul
Department of Orthopedic Surgery, Daejeon St. Mary's Hospital, The Catholic University of Korea, Seoul 34943, Republic of Korea.
Department of Bionic Machinery, KIMM Institute of AI Robot, Korea Institute of Machinery and Materials, Daejeon 34103, Republic of Korea.
J Funct Biomater. 2025 Mar 14;16(3):105. doi: 10.3390/jfb16030105.
The rising demand for organ transplants and the need for precise tissue models have positioned the in vitro biomanufacturing of tissues and organs as a pivotal area in regenerative treatment. Considerable development has been achieved in growing tissue-engineered intervertebral disc (IVD) scaffolds, designed to meet stringent mechanical and biological compatibility criteria. Among the cutting-edge approaches, 3D bioprinting stands out due to its unparalleled capacity to organize biomaterials, bioactive molecules, and living cells with high precision. Despite these advancements, polymer-based scaffolds still encounter limitations in replicating the extracellular matrix (ECM)-like environment, which is fundamental for optimal cellular activities. To overcome these challenges, integrating polymers with hydrogels has been recommended as a promising solution. This combination enables the advancement of porous scaffolds that nurture cell adhesion, proliferation, as well as differentiation. Additionally, bioinks derived from the decellularized extracellular matrix (dECM) have exhibited potential in replicating biologically relevant microenvironments, enhancing cell viability, differentiation, and motility. Hydrogels, whether derived from natural sources involving collagen and alginate or synthesized chemically, are highly valued for their ECM-like properties and superior biocompatibility. This review will explore recent advancements in techniques and technologies for IVD regeneration. Emphasis will be placed on identifying research gaps and proposing strategies to bridge them, with the goal of accelerating the translation of IVDs into clinical applications.
对器官移植的需求不断增加以及对精确组织模型的需求,使得组织和器官的体外生物制造成为再生治疗的关键领域。在生长符合严格机械和生物相容性标准的组织工程椎间盘(IVD)支架方面已经取得了相当大的进展。在前沿方法中,3D生物打印因其具有无与伦比的高精度组织生物材料、生物活性分子和活细胞的能力而脱颖而出。尽管取得了这些进展,但基于聚合物的支架在复制细胞外基质(ECM)样环境方面仍然存在局限性,而这种环境对于最佳细胞活动至关重要。为了克服这些挑战,建议将聚合物与水凝胶整合作为一种有前景的解决方案。这种组合能够推动多孔支架的发展,促进细胞黏附、增殖和分化。此外,源自脱细胞细胞外基质(dECM)的生物墨水在复制生物学相关微环境、提高细胞活力、分化和运动性方面已展现出潜力。水凝胶,无论是源自涉及胶原蛋白和藻酸盐的天然来源还是化学合成的,都因其类似ECM的特性和卓越的生物相容性而受到高度重视。本综述将探讨IVD再生技术和工艺的最新进展。重点将放在识别研究差距并提出弥补差距的策略上,目标是加速IVD向临床应用的转化。